Edwards Lifesciences Corporation Net Income (Loss) Available to Common Stockholders, Diluted
Edwards Lifesciences Corporation (EW) reported Net Income (Loss) Available to Common Stockholders, Diluted of $351.90 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-04-29.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2024-04-29
- Edwards Lifesciences Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2024-03-31 was $351.90M, a 3.35% increase year-over-year.
- Edwards Lifesciences Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2023-12-31 was $369.90M, a 7.15% decline year-over-year.
- Edwards Lifesciences Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2023-09-30 was $384.90M, a 12.05% increase year-over-year.
- Edwards Lifesciences Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2023-06-30 was $307.10M, a 24.43% decline year-over-year.
- Edwards Lifesciences Corporation net income (loss) available to common stockholders, diluted for fiscal 2023 was $1.40B, a 7.85% decline from fiscal 2022.
- Edwards Lifesciences Corporation net income (loss) available to common stockholders, diluted for fiscal 2022 was $1.52B, a 1.25% increase from fiscal 2021.
- Edwards Lifesciences Corporation net income (loss) available to common stockholders, diluted for fiscal 2021 was $1.50B.
- Edwards Lifesciences Corporation net income (loss) available to common stockholders, diluted for fiscal 2010 was $218.00M, a 4.85% decline from fiscal 2009.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2024-03-31 | $351.90M 10-Q · filed 2024-04-29 | $721.80M derived: sum of 2 quarters · filed 2024-04-29 | $1.11B derived: sum of 3 quarters · filed 2024-04-29 | $1.41B derived: sum of 4 quarters · filed 2024-04-29 |
| 2023-12-31 | $369.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $754.80M derived: sum of 2 quarters · filed 2024-02-12 | $1.06B derived: sum of 3 quarters · filed 2024-02-12 | $1.40B 10-K · filed 2024-02-12 |
| 2023-09-30 | $384.90M 10-Q · filed 2023-10-27 | $692.00M derived: sum of 2 quarters · filed 2023-10-27 | $1.03B 10-Q · filed 2023-10-27 | $1.43B derived: sum of 4 quarters · filed 2024-04-29 |
| 2023-06-30 | $307.10M 10-Q · filed 2023-07-28 | $647.60M 10-Q · filed 2023-07-28 | $1.05B derived: sum of 3 quarters · filed 2024-04-29 | $1.39B derived: sum of 4 quarters · filed 2024-04-29 |
| 2023-03-31 | $340.50M 10-Q · filed 2024-04-29 | $738.90M derived: sum of 2 quarters · filed 2024-04-29 | $1.08B derived: sum of 3 quarters · filed 2024-04-29 | $1.49B derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | $398.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $741.90M derived: sum of 2 quarters · filed 2024-02-12 | $1.15B derived: sum of 3 quarters · filed 2024-02-12 | $1.52B 10-K · filed 2024-02-12 |
| 2022-09-30 | $343.50M 10-Q · filed 2023-10-27 | $749.90M derived: sum of 2 quarters · filed 2023-10-27 | $1.12B 10-Q · filed 2023-10-27 | |
| 2022-06-30 | $406.40M 10-Q · filed 2023-07-28 | $780.00M 10-Q · filed 2023-07-28 | ||
| 2022-03-31 | $373.60M 10-Q · filed 2023-04-28 | |||
| 2021-12-31 | $1.50B 10-K · filed 2024-02-12 | |||
| 2010-12-31 | $218.00M 10-K · filed 2011-02-28 | |||
| 2009-12-31 | $229.10M 10-K · filed 2011-02-28 | |||
| 2008-12-31 | $130.60M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |